PRESENT

Shares of Galena Biopharma Inc (NASDAQ: GALE) plunged more than 30 percent Thursday morning after the company announced a public offering of common stock and warrants. Galena Biopharma, a biopharmaceutical company that focuses on oncology therapeutics, stated on Wednesday afternoon it will...